...
首页> 外文期刊>Journal of neuroinflammation >670-nm light treatment reduces complement propagation following retinal degeneration
【24h】

670-nm light treatment reduces complement propagation following retinal degeneration

机译:670 nm光治疗可减少视网膜变性后补体的传播

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Aim Complement activation is associated with the pathogenesis of age-related macular degeneration (AMD). We aimed to investigate whether 670-nm light treatment reduces the propagation of complement in a light-induced model of atrophic AMD. Methods Sprague–Dawley (SD) rats were pretreated with 9 J/cm2 670-nm light for 3 minutes daily over 5 days; other animals were sham treated. Animals were exposed to white light (1,000 lux) for 24 h, after which animals were kept in dim light (5 lux) for 7 days. Expression of complement genes was assessed by quantitative polymerase chain reaction (qPCR), and immunohistochemistry. Counts were made of C3-expressing monocytes/microglia using in situ hybridization. Photoreceptor death was also assessed using outer nuclear layer (ONL) thickness measurements, and oxidative stress using immunohistochemistry for 4-hydroxynonenal (4-HNE). Results Following light damage, retinas pretreated with 670-nm light had reduced immunoreactivity for the oxidative damage maker 4-HNE in the ONL and outer segments, compared to controls. In conjunction, there was significant reduction in retinal expression of complement genes C1s, C2, C3, C4b, C3aR1, and C5r1 following 670 nm treatment. In situ hybridization, coupled with immunoreactivity for the marker ionized calcium binding adaptor molecule 1 (IBA1), revealed that C3 is expressed by infiltrating microglia/monocytes in subretinal space following light damage, which were significantly reduced in number after 670 nm treatment. Additionally, immunohistochemistry for C3 revealed a decrease in C3 deposition in the ONL following 670 nm treatment. Conclusions Our data indicate that 670-nm light pretreatment reduces lipid peroxidation and complement propagation in the degenerating retina. These findings have relevance to the cellular events of complement activation underling the pathogenesis of AMD, and highlight the potential of 670-nm light as a non-invasive anti-inflammatory therapy.
机译:目的补体激活与年龄相关性黄斑变性(AMD)的发病机制有关。我们旨在研究670 nm的光治疗是否能减少光诱导的萎缩性AMD模型中补体的传播。方法用9 J / cm2 670 nm的光对Sprague-Dawley(SD)大鼠进行5天每天3分钟的预处理。其他动物也接受了假治疗。使动物暴露于白光(1,000 lux)下24 h,然后将它们置于昏暗的光线(5 lux)下7天。通过定量聚合酶链反应(qPCR)和免疫组织化学评估补体基因的表达。使用原位杂交计数表达C3的单核细胞/小胶质细胞。还使用外核层(ONL)厚度测量评估了光感受器死亡,并使用免疫组织化学对4-羟基壬烯醛(4-HNE)评估了氧化应激。结果光损伤后,与对照组相比,经670 nm光预处理的视网膜对ONL和外部节段中的氧化损伤产生剂4-HNE的免疫反应性降低。结合起来,670 nm处理后,补体基因C1,C2,C3,C4b,C3aR1和C5r1的视网膜表达显着降低。原位杂交,再加上标记离子化钙结合衔接子分子1(IBA1)的免疫反应性,表明C3是由光损伤后浸入视网膜下空间的小胶质细胞/单核细胞浸润而表达的,在670 nm处理后,C3的表达显着减少。此外,对C3的免疫组织化学分析显示,在670 nm处理后,ONL中C3的沉积减少。结论我们的数据表明670 nm光预处理可以减少脂质过氧化并补充变性视网膜中的补体传播。这些发现与AMD发病机制中补体激活的细胞事件有关,并突出了670 nm光作为非侵入性抗炎疗法的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号